Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(4 sites)

United States

UF Health Cancer Institute - Gainesville, Gainesville, Florida

National Cancer Institute Developmental Therapeutics Clinic, Bethesda, Maryland

National Institutes of Health Clinical Center, Bethesda, Maryland

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma